These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18576149)

  • 21. PrP fragment 106-126 is toxic to cerebral endothelial cells expressing PrP(C).
    Deli MA; Sakaguchi S; Nakaoke R; Abrahám CS; Takahata H; Kopacek J; Shigematsu K; Katamine S; Niwa M
    Neuroreport; 2000 Nov; 11(17):3931-6. PubMed ID: 11117517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeic acid phenethyl ester prevents cerebellar granule neurons (CGNs) against glutamate-induced neurotoxicity.
    Wei X; Ma Z; Fontanilla CV; Zhao L; Xu ZC; Taggliabraci V; Johnstone BH; Dodel RC; Farlow MR; Du Y
    Neuroscience; 2008 Sep; 155(4):1098-105. PubMed ID: 18657598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of the prion peptide (PrP 106-126) with brain capillary endothelial cells: coordinated cell killing and remodeling of intercellular junctions.
    Cooper I; Cohen-Kashi Malina K; Cagnotto A; Bazzoni G; Salmona M; Teichberg VI
    J Neurochem; 2011 Feb; 116(4):467-75. PubMed ID: 20804519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kisspeptin prevention of amyloid-β peptide neurotoxicity in vitro.
    Milton NG; Chilumuri A; Rocha-Ferreira E; Nercessian AN; Ashioti M
    ACS Chem Neurosci; 2012 Sep; 3(9):706-19. PubMed ID: 23019497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neurotoxicity of prion protein (PrP) peptide 106-126 is independent of the expression level of PrP and is not mediated by abnormal PrP species.
    Fioriti L; Quaglio E; Massignan T; Colombo L; Stewart RS; Salmona M; Harris DA; Forloni G; Chiesa R
    Mol Cell Neurosci; 2005 Jan; 28(1):165-76. PubMed ID: 15607951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine.
    van Vliet E; Morath S; Eskes C; Linge J; Rappsilber J; Honegger P; Hartung T; Coecke S
    Neurotoxicology; 2008 Jan; 29(1):1-12. PubMed ID: 18023877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ameliorative effect of 1,2-benzenedicarboxylic acid dinonyl ester against amyloid beta peptide-induced neurotoxicity.
    Jung Choi S; Kim MJ; Jin Heo H; Kim JK; Jin Jun W; Kim HK; Kim EK; Ok Kim M; Yon Cho H; Hwang HJ; Jun Kim Y; Shin DH
    Amyloid; 2009 Mar; 16(1):15-24. PubMed ID: 19291510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceleration of methylmercury-induced cell death of rat cerebellar neurons by brain-derived neurotrophic factor in vitro.
    Sakaue M; Mori N; Makita M; Fujishima K; Hara S; Arishima K; Yamamoto M
    Brain Res; 2009 Jun; 1273():155-62. PubMed ID: 19332029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity of prion protein peptide (PrP106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, A beta 25-35.
    Hope J; Shearman MS; Baxter HC; Chong A; Kelly SM; Price NC
    Neurodegeneration; 1996 Mar; 5(1):1-11. PubMed ID: 8731376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal prion protein in Drosophila enhances the toxicity of pathogenic polyglutamine proteins and alters susceptibility to oxidative and autophagy signaling modulators.
    Park Y; Kim W; Kim AY; Choi HJ; Choi JK; Park N; Koh EK; Seo J; Koh YH
    Biochem Biophys Res Commun; 2011 Jan; 404(2):638-45. PubMed ID: 21146501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prion organotypic slice culture assay--POSCA.
    Falsig J; Aguzzi A
    Nat Protoc; 2008; 3(4):555-62. PubMed ID: 18388937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular accumulation of a mild-denatured monomer of the human PrP fragment 90-231, as possible mechanism of its neurotoxic effects.
    Chiovitti K; Corsaro A; Thellung S; Villa V; Paludi D; D'Arrigo C; Russo C; Perico A; Ianieri A; Di Cola D; Vergara A; Aceto A; Florio T
    J Neurochem; 2007 Dec; 103(6):2597-609. PubMed ID: 17944873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of cellular glutathione by 3H-1,2-dithiole-3-thione as a possible treatment strategy for protecting against acrolein-induced neurocytotoxicity.
    Jia Z; Misra BR; Zhu H; Li Y; Misra HP
    Neurotoxicology; 2009 Jan; 30(1):1-9. PubMed ID: 19073213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture.
    Farina F; Botto L; Chinello C; Cunati D; Magni F; Masserini M; Palestini P
    J Neurochem; 2009 Aug; 110(3):1038-48. PubMed ID: 19493159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A deleted prion protein that is neurotoxic in vivo is localized normally in cultured cells.
    Christensen HM; Harris DA
    J Neurochem; 2009 Jan; 108(1):44-56. PubMed ID: 19046329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide NMHRYPNQ of the cellular prion protein (PrP(C)) inhibits aggregation and is a potential key for understanding prion-prion interactions.
    Rehders D; Claasen B; Redecke L; Buschke A; Reibe C; Jehmlich N; von Bergen M; Betzel C; Meyer B
    J Mol Biol; 2009 Sep; 392(1):198-207. PubMed ID: 19607841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PrP and beta-amyloid fragments activate different neurotoxic mechanisms in cultured mouse cells.
    Brown DR; Herms JW; Schmidt B; Kretzschmar HA
    Eur J Neurosci; 1997 Jun; 9(6):1162-9. PubMed ID: 9215699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuron dysfunction is induced by prion protein with an insertional mutation via a Fyn kinase and reversed by sirtuin activation in Caenorhabditis elegans.
    Bizat N; Peyrin JM; Haïk S; Cochois V; Beaudry P; Laplanche JL; Néri C
    J Neurosci; 2010 Apr; 30(15):5394-403. PubMed ID: 20392961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of cerebellar granule neurons is associated with punctate but not with large focal deposits of prion protein in Creutzfeldt-Jakob disease.
    Faucheux BA; Privat N; Brandel JP; Sazdovitch V; Laplanche JL; Maurage CA; Hauw JJ; Haïk S
    J Neuropathol Exp Neurol; 2009 Aug; 68(8):892-901. PubMed ID: 19606064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.